Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
OU8	S$1.70	7.6%	-4.5%	S$1.4b	S$1.88	12.5	-0.3%	2.4%	Real Estate Management and Development
AVIA	Rp328.00	0%	-22.6%	Rp19.4t	Rp496.29	10.8	5.8%	6.7%	Materials
QUEST	€7.26	0.4%	-6.9%	€768.1m	n/a	15.5	13.3%	5.5%	Tech
GABC New	US$50.33	-1.7%	27.5%	US$1.9b	US$56.20	1.6	5.6%	2.5%	Banks
NXR.UN	CA$7.88	-2.0%	0.3%	CA$756.3m	CA$8.50	0.5	6.1%	8.1%	Real Estate
BILI A	SEK 148.40	-3.6%	27.1%	SEK 13.6b	SEK 165.67	16.1	15.4%	4.0%	Retail
ORN New	US$9.77	-4.0%	40.0%	US$396.4m	US$15.32	109.8	74.8%	n/a	Capital Goods
KINS	US$19.07	-6.1%	20.9%	US$277.7m	US$21.50	7.8	16.7%	1.3%	Insurance
ECEL	UK£1.19	0.9%	-21.0%	UK£115.9m	UK£2.05	12.1	31.7%	5.4%	Capital Goods
UNB	US$24.35	3.6%	-10.5%	US$109.3m	n/a	1.2	n/a	5.9%	Banks
BMRC	US$28.47	-3.5%	23.8%	US$449.4m	US$31.80	1.1	102.5%	3.5%	Banks
ENOV New	US$24.60	-20.3%	-14.4%	US$1.4b	US$41.25	0.6	145.8%	n/a	Healthcare
NOHO	€7.91	-2.6%	-9.3%	€166.5m	€8.80	15.9	18.0%	2.9%	Consumer Services
SHBI	US$23.83	-3.2%	50.1%	US$787.6m	US$25.75	1.3	8.1%	2.4%	Banks
RCEL	US$8.20	77.1%	48.6%	US$235.0m	US$9.03	3.4	69.9%	n/a	Pharmaceuticals & Biotech
ILPT	US$8.85	2.0%	54.5%	US$583.4m	US$11.17	1.3	20.7%	4.5%	Real Estate
TPK New	UK£6.61	-2.6%	7.5%	UK£1.4b	UK£6.53	0.3	79.7%	1.8%	Capital Goods
CBNA New	US$48.22	0.8%	76.2%	US$314.4m	US$49.00	1.7	10.1%	n/a	Banks
PMZ.UN	CA$22.04	-2.7%	48.2%	CA$2.6b	CA$25.50	1.0	31.9%	4.0%	Real Estate
CEVI	SEK 154.80	4.0%	-6.9%	SEK 3.7b	SEK 175.67	28.6	17.8%	1.8%	Healthcare
LINC New	SEK 73.60	-0.5%	-7.9%	SEK 4.3b	SEK 72.00	13.0	n/a	n/a	Diversified Financials
ONT	US$16.41	-28.2%	-39.9%	US$545.7m	US$20.60	0.7	145.1%	n/a	Commercial Services
FRAN New	UK£1.50	2.9%	11.3%	UK£287.9m	UK£2.00	26.5	-1.0%	1.7%	Commercial Services
BOTJ	US$27.31	0.8%	95.4%	US$122.8m	n/a	1.5	n/a	1.5%	Banks

Undervalued Small Caps With Insider Buying